Interestingly, except for OCT1, all investigated transporters were equally (OCTN1-2) or even significantly lower expressed in breast cancer tissue (i.e., P-gp, MRP1, BCRP, OCT3, OCT6, and OATP1A2) compared to the tissue of healthy controls. This evidence concerns the gene SLC22A16 and breast cancer.